Jakub Gumprecht

Five Weeks of Treatment with the GLP-1 Analogue Liraglutide Improves Glycaemic Control and Lowers Body weight in Subjects with Type 2 Diabetes

M. Nauck, Marcus Hompesch, R. Filipczak et al. · Experimental and Clinical Endocrinology & Diabetes · 2006 · 141 citations

Comparative long‐term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20–40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia

Jakub Gumprecht, Masahiko Gosho, Dragos Budinski et al. · Diabetes Obesity and Metabolism · 2011 · 81 citations

Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix^®30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE™ observational study

P. Valensi, Marian Benroubi, Jakub Gumprecht et al. · International Journal of Clinical Practice · 2009 · 80 citations · Full text

Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix^®30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVE™ observational study

Shreyas Shah, Marian Benroubi, Jakub Gumprecht et al. · International Journal of Clinical Practice · 2009 · 44 citations · Full text

Relationship between diabetes mellitus and atrial fibrillation prevalence in the Polish population: a report from the Non-invasive Monitoring for Early Detection of Atrial Fibrillation (NOMED-AF) prospective cross-sectional observational study

Jakub Gumprecht, Gregory Y.H. Lip, Adam Sokal et al. · Cardiovascular Diabetology · 2021 · 32 citations · Full text